Lucile Capuron
Cheffe d'équipe
Directrice de recherche / INRAE/ Contact
+33 5 57 57 92 18
www.orcid.org/0000-0002-2060-5918
/ Adresse
NutriNeuro - Bâtiment UFR Pharmacie - 2e tranche – 2e étage - Case 34 - 146 rue Léo-Saignat - 33076 Bordeaux Cedex
Publications
-
Cord serum cytokines at birth and children’s trajectories of mood dysregulation symptoms from 3 to 8 years: The EDEN birth cohort.
Brain, Behavior, & Immunity - Health. 2024-07-01. 38 : 100768.
10.1016/j.bbih.2024.100768 -
Early life stress in relation with risk of overweight, depression, and their comorbidity across adulthood: findings from a British birth cohort
Psychol. Med.. 2024-01-10. 54(8) : 1853-1866.
10.1017/S0033291723003823 -
Saffron extract interferes with lipopolysaccharide-induced brain activation of the kynurenine pathway and impairment of monoamine neurotransmission in mice
Front. Nutr.. 2023-10-05. 10
10.3389/fnut.2023.1267839 -
Strain-specific changes in nucleus accumbens transcriptome and motivation for palatable food reward in mice exposed to maternal separation.
Front. Nutr.. 2023-07-26. 10
10.3389/fnut.2023.1190392 -
Acute Effect of a Saffron Extract (Safr’InsideTM) and Its Main Volatile Compound on the Stress Response in Healthy Young Men: A Randomized, Double Blind, Placebo-Controlled, Crossover Study
Nutrients. 2023-06-27. 15(13) : 2921.
10.3390/nu15132921 -
Tetrahydrobiopterin modulates the behavioral neuroinflammatory response to an LPS challenge in mice
Brain, Behavior, and Immunity. 2022-10-01. 105 : 139-148.
10.1016/j.bbi.2022.06.016 -
Preclinical animal models of mental illnesses to translate findings from the bench to the bedside: Molecular brain mechanisms and peripheral biomarkers associated to early life stress or immune challenges
European Neuropsychopharmacology. 2022-05-01. 58 : 55-79.
10.1016/j.euroneuro.2022.02.002 -
Circulating Human Serum Metabolites Derived from the Intake of a Saffron Extract (SafrInsideTM) Protect Neurons from Oxidative Stress: Consideration for Depressive Disorders
Nutrients. 2022-04-05. 14(7) : 1511.
10.3390/nu14071511 -
Low omega-3 polyunsaturated fatty acids predict reduced response to standard antidepressants in patients with major depressive disorder.
Depression and Anxiety. 2022-03-31. 39(5) : 407-418.
10.1002/da.23257 -
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers.
International Journal of Neuropsychopharmacology. 2022-02-17. 25(6) : 468-478.
10.1093/ijnp/pyac016 -
Association between the indole pathway of tryptophan metabolism and subclinical depressive symptoms in obesity: a preliminary study.
Int J Obes. 2022-01-10. 46(4) : 885-888.
10.1038/s41366-021-01049-0 -
Prevention of Stress-Induced Depressive-like Behavior by Saffron Extract Is Associated with Modulation of Kynurenine Pathway and Monoamine Neurotransmission
Pharmaceutics. 2021-12-14. 13(12) : 2155.
10.3390/pharmaceutics13122155 -
A new experimental design to study inflammation-related versus non-inflammation-related depression in mice
J Neuroinflammation. 2021-12-01. 18(1)
10.1186/s12974-021-02330-9 -
Relationship between body mass index and neuropsychiatric symptoms: Evidence and inflammatory correlates.
Brain, Behavior, and Immunity. 2021-05-01. 94 : 104-110.
10.1016/j.bbi.2021.02.031 -
From gut to brain: Microbiota depletion in mice as a tool to explore causality.
Brain, Behavior, and Immunity. 2021-05-01. 94 : 4-5.
10.1016/j.bbi.2021.02.029 -
Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry
CN. 2021-04-29. 19(5) : 591-609.
10.2174/1570159x18666200729103529 -
Transcriptomic signaling pathways involved in a naturalistic model of inflammation-related depression and its remission
Transl Psychiatry. 2021-04-06. 11(1)
10.1038/s41398-021-01323-9 -
Brain-immune crosstalk in the treatment of major depressive disorder
European Neuropsychopharmacology. 2021-04-01. 45 : 89-107.
10.1016/j.euroneuro.2020.11.016 -
Saffron Extract-Induced Improvement of Depressive-Like Behavior in Mice Is Associated with Modulation of Monoaminergic Neurotransmission
Nutrients. 2021-03-11. 13(3) : 904.
10.3390/nu13030904 -
Cord Serum Cytokines at Birth and Children’s Anxiety-Depression Trajectories From 3 to 8 Years: The EDEN Mother-Child Cohort.
Biological Psychiatry. 2021-03-01. 89(6) : 541-549.
10.1016/j.biopsych.2020.10.009 -
Effects of saffron extract supplementation on mood, well-being, and response to a psychosocial stressor in healthy adults: a randomized, double-blind, parallel group, clinical trial
Front. Nutr.. 2021-02-01. 7
10.3389/fnut.2020.606124 -
Inflammatory Bases of Neuropsychiatric Symptom Domains: Mechanisms and Specificity.
Immuno-Psychiatry. 2021-01-01. : 335-353.
10.1007/978-3-030-71229-7_20 -
Dietary vitamin A supplementation prevents early obesogenic diet-induced microbiota, neuronal and cognitive alterations
Int J Obes. 2020-11-22.
10.1038/s41366-020-00723-z -
Cord Serum Cytokines at Birth and Children’s Anxiety/Depression Trajectories from 3 to 8 Years: The EDEN Mother-Child Cohort
Biological Psychiatry. 2020-10-01.
10.1016/j.biopsych.2020.10.009 -
Tryptophan Metabolic Pathways Are Altered in Obesity and Are Associated With Systemic Inflammation
Front. Immunol.. 2020-04-15. 11
10.3389/fimmu.2020.00557 -
Reward-related brain activity and behavior are associated with peripheral ghrelin levels in obesity
Psychoneuroendocrinology. 2020-02-01. 112 : 104520.
10.1016/j.psyneuen.2019.104520 -
Tetrahydrobiopterin administration facilitates amphetamine-induced dopamine release and motivation in mice
Behavioural Brain Research. 2020-02-01. 379 : 112348.
10.1016/j.bbr.2019.112348 -
Association of chronic inflammation and perceived stress with abnormal functional connectivity in brain areas involved with interoception in hepatitis C patients.
Brain, Behavior, and Immunity. 2019-08-01. 80 : 204-218.
10.1016/j.bbi.2019.03.008 -
Multi-hit early life adversity affects gut microbiota, brain and behavior in a sex-dependent manner
Brain Behav Immun.. 2019-03-11.
10.1016/j.bbi.2019.03.006 -
Brain tumor necrosis factor-α mediates anxiety-like behavior in a mouse model of severe obesity.
Brain, Behavior, and Immunity. 2018-11-01.
10.1016/j.bbi.2018.11.316 -
Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study).
Front. Psychiatry. 2018-07-24. 9
10.3389/fpsyt.2018.00326 -
Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms.
Front. Neurosci.. 2018-07-24. 12
10.3389/fnins.2018.00499 -
Polyphenols from grape and blueberry improve episodic memory in healthy elderly with lower level of memory performance: a bicentric double-blind, randomized, placebo-controlled clinical study.
The Journals of Gerontology: Series A. 2018-07-19.
10.1093/gerona/gly166 -
Depressive symptoms in obesity: Relative contribution of low-grade inflammation and metabolic health.
Psychoneuroendocrinology. 2018-05-01. 91 : 55-61.
10.1016/j.psyneuen.2018.02.030 -
Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition.
Ageing Research Reviews. 2017-11-01. 40 : 95-119.
10.1016/j.arr.2017.09.001 -
Impact of prebiotics on metabolic and behavioral alterations in a mouse model of metabolic syndrome.
Brain, Behavior, and Immunity. 2017-08-01. 64 : 33-49.
10.1016/j.bbi.2016.12.022 -
Obesity in French Inmates: Gender Differences and Relationship with Mood, Eating Behavior and Physical Activity.
PLoS ONE. 2017-01-19. 12(1) : e0170413.
10.1371/journal.pone.0170413 -
Inflammatory, endocrine and metabolic correlates of fatigue in obese children.
Psychoneuroendocrinology. 2016-12-01. 74 : 158-163.
10.1016/j.psyneuen.2016.09.002 -
Low-grade inflammation is a major contributor of impaired attentional set shifting in obese subjects.
Brain, Behavior, and Immunity. 2016-11-01. 58 : 63-68.
10.1016/j.bbi.2016.05.013 -
Role of Adiposity-Driven Inflammation in Depressive Morbidity.
Neuropsychopharmacol. 2016-07-11. 42(1) : 115-128.
10.1038/npp.2016.123 -
Role of Inflammation in the Development of Neuropsychiatric Symptom Domains: Evidence and Mechanisms.
Inflammation-Associated Depression: Evidence, Mechanisms and Implications. 2016-01-01. : 31-44.
10.1007/7854_2016_14 -
How French subjects describe well-being from food and eating habits? Development, item reduction and scoring definition of the Well-Being related to Food Questionnaire (Well-BFQ©).
Appetite. 2016-01-01. 96 : 333-346.
10.1016/j.appet.2015.09.021 -
External Validity of the Well-Being Related to Food Questionnaire (Well-Bfq©): Variations According to the Subjects’ Nutritional Status.
Value in Health. 2015-11-01. 18(7) : A711.
10.1016/j.jval.2015.09.2679 -
How French Subjects Describe Well-Being from food and Eating Habits? Development, and Scoring Definition of the well-Being Related to food Questionnaire (Well-Bfq©).
Value in Health. 2015-11-01. 18(7) : A712.
10.1016/j.jval.2015.09.2684 -
High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome.
BMC Cardiovasc Disord. 2015-03-18. 15(1)
10.1186/s12872-015-0015-3 -
Juvenile obesity enhances emotional memory and amygdala plasticity through glucocorticoids.
Journal of Neuroscience. 2015-03-04. 35(9) : 4092-4103.
10.1523/jneurosci.3122-14.2015 -
Prophylactic antidepressant treatment of interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis.
J. Clin. Psychiatry. 2014-10-28. 75(10) : e1113-e1121.
10.4088/jcp.13r08800 -
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion.
Transl Psychiatry. 2014-10-01. 4(10) : e468-e468.
10.1038/tp.2014.108 -
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion.
Transl Psychiatry. 2014-09-01. 4(9) : e437-e437.
10.1038/tp.2014.77 -
Cytokine-induced depression: current status and novel targets for depression therapy.
CNSNDDT. 2014-06-12. 13(6) : 1066-1074.
10.2174/1871527313666140612121921 -
Neuropsychiatric comorbidity in obesity: role of inflammatory processes.
Front. Endocrinol.. 2014-05-15. 5
10.3389/fendo.2014.00074 -
Activated immune system and inflammation in healthy ageing: relevance for tryptophan and neopterin metabolism.
CPD. 2014-03-17. 20(38) : 6048-6057.
10.2174/1381612820666140317110217 -
The neuroimmune basis of fatigue.
Trends in Neurosciences. 2014-01-01. 37(1) : 39-46.
10.1016/j.tins.2013.10.003 -
Chronic low-grade inflammation in metabolic disorders: relevance for behavioral symptoms.
Neuroimmunomodulation. 2014-01-01. 21(2-3) : 95-101.
10.1159/000356535 -
Adipose inflammation in obesity: relationship with circulating levels of inflammatory markers and association with surgery-induced weight loss.
The Journal of Clinical Endocrinology & Metabolism. 2014-01-01. 99(1) : E53-E61.
10.1210/jc.2013-2673 -
Sleep disruption in breast cancer patients and survivors.
J Natl Compr Canc Netw. 2013-12-01. 11(12) : 1523-1530.
10.6004/jnccn.2013.0179 -
A response to the commentary « Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms » by Loftis, J.M. on « Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms »
Psychoneuroendocrinology. 2013-09-01. 38(9) : 1830-1831.
10.1016/j.psyneuen.2013.05.019 -
Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.
Psychoneuroendocrinology. 2013-09-01. 38(9) : 1803-1813.
10.1016/j.psyneuen.2013.03.007 -
Quality of life after Roux-en-Y gastric bypass and changes in body mass index and obesity-related comorbidities.
Diabetes & Metabolism. 2013-04-01. 39(2) : 148-154.
10.1016/j.diabet.2012.10.008 -
Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement.
Journal of Hepatology. 2012-12-01. 57(6) : 1379-1390.
10.1016/j.jhep.2012.07.037 -
Fatigue symptoms relate to systemic inflammation in patients with type 2 diabetes.
Brain, Behavior, and Immunity. 2012-11-01. 26(8) : 1211-1219.
10.1016/j.bbi.2012.03.003 -
Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.
Arch Gen Psychiatry. 2012-10-01. 69(10) : 1044.
10.1001/archgenpsychiatry.2011.2094 -
Fatigue and cognitive symptoms in patients with diabetes: relationship with disease phenotype and insulin treatment.
Psychoneuroendocrinology. 2012-09-01. 37(9) : 1468-1478.
10.1016/j.psyneuen.2012.01.016 -
Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms.
Biological Psychiatry. 2011-07-01. 70(2) : 175-182.
10.1016/j.biopsych.2010.12.006 -
Immune system to brain signaling: neuropsychopharmacological implications.
Pharmacology & Therapeutics. 2011-05-01. 130(2) : 226-238.
10.1016/j.pharmthera.2011.01.014 -
Immune system to brain signaling: neuropsychopharmacological implications.
Pharmacology & Therapeutics. 2011-05-01. 130(2) : 226-238.
10.1016/j.pharmthera.2011.01.014 -
Relationship between adiposity, emotional status and eating behaviour in obese women: role of inflammation.
Psychol. Med.. 2010-10-20. 41(07) : 1517-1528.
10.1017/s0033291710001984 -
Association of childhood trauma with cognitive function in healthy adults: a pilot study.
BMC Neurol. 2010-07-14. 10(1)
10.1186/1471-2377-10-61 -
Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?
Journal of Affective Disorders. 2009-12-01. 119(1-3) : 181-185.
10.1016/j.jad.2009.02.017 -
Vitamin E status and quality of life in the elderly: influence of inflammatory processes.
Br J Nutr. 2009-06-01. 102(10) : 1390.
10.1017/S0007114509990493 -
Inflammation, sickness behaviour and depression
Depression and Physical Illness. . : 265-279.
10.1017/cbo9780511544293.013 -
Depressive symptoms and metabolic syndrome: is inflammation the underlying link?
Biological Psychiatry. 2008-11-01. 64(10) : 896-900.
10.1016/j.biopsych.2008.05.019 -
Dietary patterns derived by hybrid clustering method in older people: association with cognition, mood, and self-rated health.
Journal of the American Dietetic Association. 2008-09-01. 108(9) : 1461-1471.
10.1016/j.jada.2008.06.437 -
Neuropsychological performance in persons with chronic fatigue syndrome: results from a population-based study.
Psychosomatic Medicine. 2008-09-01. 70(7) : 829-836.
10.1097/psy.0b013e31817b9793 -
IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C.
Brain, Behavior, and Immunity. 2008-08-01. 22(6) : 870-880.
10.1016/j.bbi.2007.12.009 -
Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.
JCO. 2008-02-20. 26(6) : 971-982.
10.1200/JCO.2007.10.7805 -
Identification and treatment of symptoms associated with inflammation in medically ill patients.
Psychoneuroendocrinology. 2008-01-01. 33(1) : 18-29.
10.1016/j.psyneuen.2007.10.008 -
Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy.
Neuropsychopharmacol. 2007-02-28. 32(11) : 2384-2392.
10.1038/sj.npp.1301362 -
Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome.
Neuropsychopharmacology. 2006-01-04. 31(8) : 1777-1784.
10.1038/sj.npp.1301005 -
Cytokines sing the blues: inflammation and the pathogenesis of depression.
Trends in Immunology. 2006-01-01. 27(1) : 24-31.
10.1016/j.it.2005.11.006 -
Anterior cingulate activation and error processing during interferon-alpha treatment.
Biological Psychiatry. 2005-08-01. 58(3) : 190-196.
10.1016/j.biopsych.2005.03.033 -
Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction.
J. Clin. Psychiatry. 2005-01-15. 66(01) : 41-48.
10.4088/jcp.v66n0106 -
Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C.
Brain, Behavior, and Immunity. 2005-01-01. 19(1) : 23-27.
10.1016/j.bbi.2004.05.001 -
Neuropsychiatric adverse effects of interferon-alpha: recognition and management.
CNS Drugs. 2005-01-01. 19(2) : 105-123.
10.2165/00023210-200519020-00002 -
Cytokines and psychopathology: lessons from interferon-alpha.
Biological Psychiatry. 2004-12-01. 56(11) : 819-824.
10.1016/j.biopsych.2004.02.009 -
Plasma homocysteine and immune activation in patients with malignant melanoma undergoing treatment with IFN-alpha.
Journal of Interferon & Cytokine Research. 2004-05-01. 24(5) : 311-317.
10.1089/107999004323065101 -
Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.
Brain, Behavior, and Immunity. 2004-05-01. 18(3) : 205-213.
10.1016/j.bbi.2003.11.004 -
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.
Biological Psychiatry. 2003-11-01. 54(9) : 906-914.
10.1016/s0006-3223(03)00173-2 -
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.
AJP. 2003-07-01. 160(7) : 1342-1345.
10.1176/appi.ajp.160.7.1342 -
Cytokines and depression: the need for a new paradigm.
Brain, Behavior, and Immunity. 2003-02-01. 17(1) : 119-124.
10.1016/s0889-1591(02)00078-8 -
Treatment of cytokine-induced depression.
Brain, Behavior, and Immunity. 2002-10-01. 16(5) : 575-580.
10.1016/s0889-1591(02)00007-7 -
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.
Mol Psychiatry. 2002-06-01. 7(5) : 468-473.
10.1038/sj.mp.4000995 -
Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.
Neuropsychopharmacology. 2002-05-01. 26(5) : 643-652.
10.1016/s0893-133x(01)00407-9 -
Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy.
Psychoneuroendocrinology. 2001-11-01. 26(8) : 797-808.
10.1016/s0306-4530(01)00030-0 -
Cytokines in clinical psychiatry.
AJP. 2001-07-01. 158(7) : 1163-1163.
10.1176/appi.ajp.158.7.1163 -
Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients.
Psychosomatic Medicine. 2001-05-01. 63(3) : 376-386.
10.1097/00006842-200105000-00007 -
Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy.
Neuropsychopharmacology. 2001-02-01. 24(2) : 130-140.
10.1016/s0893-133x(00)00168-8 -
Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy.
JCO. 2000-05-10. 18(10) : 2143-2151.
10.1200/jco.2000.18.10.2143 -
Prediction of the depressive effects of interferon alfa therapy by the patient’s initial affective state.
N Engl J Med. 1999-04-29. 340(17) : 1370-1370.
10.1056/nejm199904293401716 -
Attentional and mnemonic deficits associated with infectious disease in humans.
Psychol. Med.. 1999-03-01. 29(2) : 291-297.
10.1017/s0033291798007740